Published in Eur Urol on March 30, 2010
The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation. World J Urol (2014) 0.87
Efficacy of percutaneous cryoablation of renal cell carcinoma in older patients with medical comorbidities: Outcome study in 70 patients. Can Urol Assoc J (2015) 0.78
Editorial comment on: complications of laparoscopic and percutaneous renal cryoablation in a single tertiary referral center. Eur Urol (2010) 0.75
Management of Urinoma Formation After Laparoscopic Cryoablation of Renal Cyst. J Endourol Case Rep (2017) 0.75
Indications for biopsy and the current status of focal therapy for renal tumours. Transl Androl Urol (2015) 0.75
Laparoscopic cryoablation vs. percutaneous cryoablation for treatment of small renal masses: a systematic review and meta-analysis. Oncotarget (2017) 0.75
Computed Tomography Perfusion, Magnetic Resonance Imaging, and Histopathological Findings After Laparoscopic Renal Cryoablation: An In Vivo Pig Model. Technol Cancer Res Treat (2016) 0.75
Liver biopsy. Hepatology (2009) 7.61
Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy. Eur Urol (2008) 4.75
Detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institutional study. J Urol (2013) 2.76
Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening. J Urol (2007) 2.42
Prospective randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less. J Urol (2008) 2.40
The state of prostate MRI in 2013. Oncology (Williston Park) (2013) 2.33
Prospective, randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less. J Urol (2005) 2.31
Dual-energy multidetector CT: how does it work, what can it tell us, and when can we use it in abdominopelvic imaging? Radiographics (2010) 2.27
Pathologic stage T2a and T2b prostate cancer in the recent prostate-specific antigen era: implications for unilateral ablative therapy. Prostate (2008) 2.16
Public survey and survival data do not support recommendations to discontinue prostate-specific antigen screening in men at age 75. Urology (2009) 2.09
Office-based unsedated small-caliber endoscopy is equivalent to conventional sedated endoscopy in screening and surveillance for Barrett's esophagus: a randomized and blinded comparison. Am J Gastroenterol (2006) 2.07
Tumor percent involvement predicts prostate specific antigen recurrence after radical prostatectomy only in men with smaller prostate. J Urol (2010) 2.05
Journal Club: incidental thyroid nodules detected at imaging: can diagnostic workup be reduced by use of the Society of Radiologists in Ultrasound recommendations and the three-tiered system? AJR Am J Roentgenol (2014) 2.05
Use of 111in-capromab pendetide immunoscintigraphy to image localized prostate cancer foci within the prostate gland. J Urol (2009) 2.03
Promoter hypermethylation profile of kidney cancer. Clin Cancer Res (2004) 2.02
Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiol Biomarkers Prev (2008) 1.99
Rationale for percutaneous biopsy and histologic characterisation of renal tumours. Eur Urol (2012) 1.95
Effects of aerobic vs. resistance training on visceral and liver fat stores, liver enzymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT/RT. Am J Physiol Endocrinol Metab (2011) 1.91
Bilateral focal ablation of prostate tissue using low-energy direct current (LEDC): a preclinical canine study. BJU Int (2013) 1.89
Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras. J Urol (2009) 1.85
A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Ann Surg (2010) 1.83
Pain after percutaneous nephrolithotomy: impact of nephrostomy tube size. J Endourol (2003) 1.83
Acoustic radiation force impulse imaging of the abdomen: demonstration of feasibility and utility. Ultrasound Med Biol (2005) 1.73
Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years. BJU Int (2007) 1.71
Defining potency: a comparison of the International Index of Erectile Function short version and the Expanded Prostate Cancer Index Composite. Cancer (2008) 1.71
Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol (2004) 1.70
Geographic variations in the use of medical and surgical therapies for benign prostatic hyperplasia. J Urol (2006) 1.67
Determining the incidence of horseshoe kidney from radiographic data at a single institution. J Urol (2003) 1.64
Positive surgical margins after robotic assisted radical prostatectomy: a multi-institutional study. J Urol (2011) 1.62
Reduced radiation exposure with the use of an air retrograde pyelogram during fluoroscopic access for percutaneous nephrolithotomy. J Endourol (2011) 1.61
Making the diagnosis of acute appendicitis: do more preoperative CT scans mean fewer negative appendectomies? A 10-year study. Radiology (2010) 1.60
Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death. Cancer (2010) 1.59
Factors predicting prostatic biopsy Gleason sum under grading. J Urol (2009) 1.59
The surgical management of stones in patients with urinary diversions. Curr Opin Urol (2004) 1.54
Central venous catheter integrity during mechanical power injection of iodinated contrast medium. Radiology (2009) 1.53
Training, credentialing, proctoring and medicolegal risks of robotic urological surgery: recommendations of the society of urologic robotic surgeons. J Urol (2009) 1.53
Pancreatic FNA in 1000 cases: a comparison of imaging modalities. Gastrointest Endosc (2005) 1.52
Comparison of three different tools for prediction of seminal vesicle invasion at radical prostatectomy. Eur Urol (2012) 1.50
Bariatric embolization for suppression of the hunger hormone ghrelin in a porcine model. Radiology (2012) 1.49
Focal therapy for prostate cancer is a reasonable treatment option in properly selected patients. Urology (2009) 1.49
Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer. Clin Trials (2008) 1.48
Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. J Urol (2002) 1.48
Pretreatment expectations of patients undergoing robotic assisted laparoscopic or open retropubic radical prostatectomy. J Urol (2012) 1.47
Current status of minimally invasive ablative techniques in the treatment of small renal tumours. Eur Urol (2006) 1.47
Initial prostate specific antigen 1.5 ng/ml or greater in men 50 years old or younger predicts higher prostate cancer risk. J Urol (2010) 1.45
Third prize: the role of endoscopic nephron-sparing surgery in the management of upper tract urothelial carcinoma. J Endourol (2011) 1.45
Predicting occult multifocality of renal cell carcinoma. Eur Urol (2010) 1.45
Effect of age and pathologic Gleason score on PSA recurrence: analysis of 2911 patients undergoing radical prostatectomy. Urology (2009) 1.44
Hypervascular liver tumors: low tube voltage, high tube current multi-detector row CT for enhanced detection--phantom study. Radiology (2008) 1.44
ACR Appropriateness Criteria® acute pancreatitis. Ultrasound Q (2014) 1.44
Predictors of biochemical failure in patients undergoing prostate whole-gland salvage cryotherapy: a novel risk stratification model. BJU Int (2013) 1.44
EUS characteristics of Nissen fundoplication: normal appearance and mechanisms of failure. Gastrointest Endosc (2006) 1.43
Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer. BJU Int (2011) 1.37
Acute appendicitis: added diagnostic value of coronal reformations from isotropic voxels at multi-detector row CT. Radiology (2005) 1.37
Helical CT for nephrolithiasis and ureterolithiasis: comparison of conventional and reduced radiation-dose techniques. Radiology (2003) 1.35
Emerging applications for ferumoxytol as a contrast agent in MRI. J Magn Reson Imaging (2014) 1.35
Hypervascular liver tumors: low tube voltage, high tube current multidetector CT during late hepatic arterial phase for detection--initial clinical experience. Radiology (2009) 1.34
Simultaneous combined use of flexible ureteroscopy and percutaneous nephrolithotomy to reduce the number of access tracts in the management of complex renal calculi. BJU Int (2005) 1.30
Treatment of localised renal cell carcinoma. Eur Urol (2011) 1.29
Prostate cancer laterality as a rationale of focal ablative therapy for the treatment of clinically localized prostate cancer. Cancer (2007) 1.27
Subcutaneous bupivacaine infiltration and postoperative pain perception after percutaneous nephrolithotomy. J Urol (2007) 1.24
Local cost structures and the economics of robot assisted radical prostatectomy. J Urol (2005) 1.23
Comparison of MR cholangiopancreatographic techniques with contrast-enhanced cholangiography in the evaluation of sclerosing cholangitis. AJR Am J Roentgenol (2002) 1.23
Effect of ureteral access sheath on stone-free rates in patients undergoing ureteroscopic management of renal calculi. Urology (2005) 1.22
Changes in Gleason score grading and their effect in predicting outcome after radical prostatectomy. Urology (2009) 1.18
State of the art: dual-energy CT of the abdomen. Radiology (2014) 1.17
Impact of dual-energy multi-detector row CT with virtual monochromatic imaging on renal cyst pseudoenhancement: in vitro and in vivo study. Radiology (2014) 1.16
Significant discrepancies between diagnostic and pathologic Gleason sums in prostate cancer: the predictive role of age and prostate-specific antigen. Urology (2008) 1.15
In vivo guidance and assessment of liver radio-frequency ablation with acoustic radiation force elastography. Ultrasound Med Biol (2008) 1.13
Hand assisted laparoscopic training for postgraduate urologists: the role of mentoring. J Urol (2004) 1.11
Complications after percutaneous radiofrequency ablation of renal tumors. Urology (2005) 1.10
Dual-energy multi-detector row CT with virtual monochromatic imaging for improving patient-to-patient uniformity of aortic enhancement during CT angiography: an in vitro and in vivo study. Radiology (2014) 1.09
Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer. Hum Gene Ther (2003) 1.08
Practice patterns in percutaneous image-guided intraabdominal abscess drainage: survey of academic and private practice centers. Radiology (2004) 1.08
Evaluation of a novel precision template-guided biopsy system for detecting prostate cancer. BJU Int (2008) 1.07
Editorial comment to Manually controlled targeted prostate biopsy with real-time fusion imaging of multiparametric magnetic resonance imaging and transrectal ultrasound: an early experience. Int J Urol (2014) 1.07
Radiation dose reduction in abdominal computed tomography during the late hepatic arterial phase using a model-based iterative reconstruction algorithm: how low can we go? Invest Radiol (2012) 1.07
Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer? Urol Oncol (2009) 1.07
Acoustic radiation force impulse imaging of human prostates: initial in vivo demonstration. Ultrasound Med Biol (2011) 1.06